Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
Disease Category: Bipolar Disorder
Location: United States, IL
A double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with acute mania associated with Bipolar I Disorder
To evaluate the efficacy, safety, and tolerability of cariprazine monotherapy
versus placebo for the treatment of acute manic or mixed episodes associated
with bipolar I disorder. For safety reasons, patients will be asked to be
hospitalized during the screening phase and for a minimum of 2 weeks during
the treatment period.
Please contact Alexian Brothers for more information on participation.
CW ID: 176868
Date Last Changed:
July 22, 2013
Alexian Brothers Hospital Network1786 Moon Lake Blvd, Suite 200Hoffman Estates, IL 60169Phone: 847-230-3599
Research Center Information: Alexian Brothers Hospital Network
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.